We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVER icon
2826
EverQuote
EVER
$861M
$23K ﹤0.01%
878
-8,090
-90% -$185K
SIBN icon
2827
SI-BONE Inc
SIBN
$848M
$23K ﹤0.01%
1,639
-1,966
-55% -$31.7K
PRTA icon
2828
Prothena Corp
PRTA
$455M
$23K ﹤0.01%
1,894
-14,932
-89% -$211K
DCH
2829
Dauch Corp
DCH
$1.6B
$22.9K ﹤0.01%
5,633
-6,346
-53% -$32.6K
TILE icon
2830
Interface
TILE
$2.19B
$22.9K ﹤0.01%
1,155
-1,603
-58% -$35K
SNCY
2831
DELISTED
Sun Country Airlines
SNCY
$22.9K ﹤0.01%
1,858
-31,827
-94% -$493K
QVCGB
2832
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$22.9K ﹤0.01%
69
-1
-1% -$216
VRDN icon
2833
Viridian Therapeutics
VRDN
$2.5B
$22.9K ﹤0.01%
1,678
-32,494
-95% -$553K
SD icon
2834
SandRidge Energy
SD
$520M
$22.8K ﹤0.01%
1,998
-9,140
-82% -$108K
ALRS icon
2835
Alerus Financial
ALRS
$838M
$22.8K ﹤0.01%
1,236
-41
-3% -$815
EQBK icon
2836
Equity Bancshares
EQBK
$1.06B
$22.8K ﹤0.01%
578
+164
+40% +$6.88K
HSTM icon
2837
HealthStream
HSTM
$846M
$22.7K ﹤0.01%
705
+236
+50% +$7.65K
NRC icon
2838
NRC Health Common Stock
NRC
$469M
$22.7K ﹤0.01%
1,772
-735
-29% -$11.8K
PLAY icon
2839
Dave & Buster's
PLAY
$354M
$22.7K ﹤0.01%
1,290
-341
-21% -$8.07K
NG icon
2840
NovaGold Resources
NG
$3.48B
$22.7K ﹤0.01%
7,759
-1,113
-13% -$3.58K
ABUS icon
2841
Arbutus Biopharma
ABUS
$924M
$22.6K ﹤0.01%
6,485
-6,294
-49% -$21K
FWRG icon
2842
First Watch Restaurant Group
FWRG
$785M
$22.6K ﹤0.01%
1,359
+697
+105% +$13.4K
OEC icon
2843
Orion
OEC
$364M
$22.6K ﹤0.01%
1,750
-5,540
-76% -$78.3K
PHAT icon
2844
Phathom Pharmaceuticals
PHAT
$775M
$22.6K ﹤0.01%
3,608
-806
-18% -$4.89K
SITE icon
2845
SiteOne Landscape Supply
SITE
$4.3B
$22.6K ﹤0.01%
186
-1,651
-90% -$219K
PLUS icon
2846
ePlus
PLUS
$2.31B
$22.6K ﹤0.01%
370
-422
-53% -$29.8K
SLS icon
2847
SELLAS Life Sciences
SLS
$2.58B
$22.6K ﹤0.01%
20,889
+15,584
+294% +$18.5K
LILA icon
2848
Liberty Latin America Class A
LILA
$1.69B
$22.5K ﹤0.01%
5,236
-51,520
-91% -$235K
ONT
2849
Onterris Inc
ONT
$619M
$22.5K ﹤0.01%
1,577
+897
+132% +$17.1K
MXL icon
2850
MaxLinear
MXL
$7.69B
$22.5K ﹤0.01%
2,070
-8,609
-81% -$144K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.